Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED | N.MMED.WA | N.MMED.WR | N.MMED.WS

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Comment by strannickon Jun 12, 2012 1:51am
240 Views
Post# 20002330

RE: RE: RE: RE: RE: Technical Viewpoint - Longterm

RE: RE: RE: RE: RE: Technical Viewpoint - LongtermThanks for the response. Governments, not markets, now set interest rates. Governments also have a monopoly on currency. 'Give me control of a nations currency and I care not who makes its laws' said the banker. The London Gold Pool of the late 60s was created to flood the market with central bank gold to maintain the Bretton Woods. Its an historical fact. Convincing arguments have been made that the same activity is now continuing serruptiously through mediums such as GLD, Comex, unallocated/allocated gold, ect. I believe the parts from Zerohedge GATA Ted Butler and others which I find convincing. When it comes to determining what is real in dog eat dog markets or otherwise, its every man for himself. My investing strategy is based on the assumption that governments control interest rates and suppress a rising tattletale gold price with the aide of primary dealer/bullion banks and are enabled by captured regulatory agencies such as the CFTC.I'm satisfied with my returns so far, so I'll keep investing.>
Bullboard Posts